Article
Ethnic differences in the frequency of the cardioprotective C679X PCSK9 mutation in a West African population.
Genetic testing - 1 Sept 2008
Sirois Francine, Gbeha Elias, Sanni Ambaliou, Chretien Michel, Labuda Damian, Mbikay Majambu
Abstract excerpt
PCSK9 is a liver-secreted blood protein that promotes the degradation of low-density lipoprotein receptors, leading to reduced hepatic uptake of plasma cholesterol. Nucleotide variations in its gene have been linked to hypo- and hyper-cholesterolemia. Two nonsense mutations, Y142X and C679X, are associated to lifelong hypocholesterolemia and a remarkable protection against coronary heart disease (CHD) in African...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
